Natalizumab

The COX4NB antibody from Proteintech is a mouse monoclonal antibody to a recombinant protein of human COX4NB. This antibody recognizes human,mouse,rat antigen.

The COX4NB antibody from Proteintech is a rabbit polyclonal antibody to a fusion protein of human COX4NB. This antibody recognizes human,mouse,rat antigen. The COX4NB antibody has been validated for the following applications: WB, ELISA analysis.

Dalotuzumab (anti-IGF1R) is a recombinant humanized monoclonal antibody (IgG1 type) targeting IGF-1R. Dalotuzumab (anti-IGF1R) acts by inhibiting IGF-1- and IGF-2-mediated tumor cell proliferation, IGF-1R autophosphorylation, and Akt phosphorylation.

Dalotuzumab (anti-IGF1R) is a recombinant humanized monoclonal antibody (IgG1 type) targeting IGF-1R. Dalotuzumab (anti-IGF1R) acts by inhibiting IGF-1- and IGF-2-mediated tumor cell proliferation, IGF-1R autophosphorylation, and Akt phosphorylation.

Dalotuzumab (anti-IGF1R) is a recombinant humanized monoclonal antibody (IgG1 type) targeting IGF-1R. Dalotuzumab (anti-IGF1R) acts by inhibiting IGF-1- and IGF-2-mediated tumor cell proliferation, IGF-1R autophosphorylation, and Akt phosphorylation.

Dalotuzumab (anti-IGF1R) is a recombinant humanized monoclonal antibody (IgG1 type) targeting IGF-1R. Dalotuzumab (anti-IGF1R) acts by inhibiting IGF-1- and IGF-2-mediated tumor cell proliferation, IGF-1R autophosphorylation, and Akt phosphorylation.

Elgemtumab (anti-ERBB3) is a fully human IgG monoclonal antibody. Elgemtumab (anti-ERBB3) can specifically bind to HER3, block ligand-dependent and independent HER3 signal transduction and cell proliferation, and has good anti-tumor

Elgemtumab (anti-ERBB3) is a fully human IgG monoclonal antibody. Elgemtumab (anti-ERBB3) can specifically bind to HER3, block ligand-dependent and independent HER3 signal transduction and cell proliferation, and has good anti-tumor

Elgemtumab (anti-ERBB3) is a fully human IgG monoclonal antibody. Elgemtumab (anti-ERBB3) can specifically bind to HER3, block ligand-dependent and independent HER3 signal transduction and cell proliferation, and has good anti-tumor

Elgemtumab (anti-ERBB3) is a fully human IgG monoclonal antibody. Elgemtumab (anti-ERBB3) can specifically bind to HER3, block ligand-dependent and independent HER3 signal transduction and cell proliferation, and has good anti-tumor

Elotuzumab is a humanized monoclonal antibody that binds human signaling lymphocytic activation molecule F7 (hSLAMF7, also known as CS1, CD319, or CRACC). Elotuzumab shows a dual mechanism of action that includes the direct activation of natural

Emactuzumab (anti-CSF1R) is a specific monoclonal antibody that inhibits colonystimulating factor 1 receptor (CSF1R) activation. Emactuzumab (anti-CSF1R) has high affinity for CSF-1R with Ki value of 0.2 nM to blocks CSF-1R dimerization. Emactuzumab